BioCryst Pharmaceuticals, Inc. (BCRX) Upgraded to "Sell" at BidaskClub


Several other research firms have also commented on BCRX. Noble Financial reaffirmed a buy rating on shares of BioCryst Pharmaceuticals in a report on Saturday, May 6th.



from Biotech News